Nurse‐like cells show deregulated expression of genes involved in immunocompetence
Open Access
- 25 May 2011
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 154 (3) , 349-356
Abstract
Summary: Chronic lymphocytic leukaemia (CLL) cells convert CD14+ cells from patients into ‘nurse‐like’ cells (NLCs). CLL cells can also convert CD14+ peripheral blood mononuclear cells (PBMCs) from healthy donors into cells with morphological similarities to NLCs (CD14CLL‐cells). However it is unclear whether only CLL cells induce this conversion process. This study showed that CD14+ PBMCs from healthy donors could also be converted into differentiated cells (CD14B‐cells) by non‐malignant B‐cells. In order to identify changes specifically induced by CLL cells, we compared gene expression profiles of NLCs, CD14CLL‐cells and CD14B‐cells. CD14+ cells cultured with CLL cells were more similar to NLCs than those cultured with non‐malignant B‐cells. The most significant changes induced by CLL cells were deregulation of the antigen presentation pathway and of genes related to immunity. NLCs had reduced levels of lysozyme activity, CD74 and HLA‐DR in‐vitro while expression of inhibitory FCGR2B was increased. These findings suggest an impaired immunocompetence of NLCs which, if found in‐vivo, could contribute to the immunodeficiency in CLL patients.Keywords
This publication has 24 references indexed in Scilit:
- Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral bloodLeukemia, 2011
- Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cellsBritish Journal of Haematology, 2010
- How I treat CLL up frontBlood, 2010
- Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemiaLeukemia, 2009
- Molecular analysis of expression and function of hFcγRIIbl and b2 isoforms in myeloid cellsMolecular Immunology, 2006
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Failure of B Cells of Chronic Lymphocytic Leukemia in Presenting Soluble and AlloantigensClinical Immunology and Immunopathology, 1995
- Infections in Chronic Lymphocytic Leukemia: Risk Factors, and Impact on Survival, and TreatmentLeukemia & Lymphoma, 1994
- Spontaneous programmed death (apoptosis) of B‐chronic lymphocytic leukaemia cells following their culture in vitroBritish Journal of Haematology, 1989
- Reduced natural killer T‐cells in B‐cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu‐11, A10, AB8.28British Journal of Haematology, 1986